A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update
Titel:
A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update
Auteur:
Sternberg, Cora N. Hawkins, Robert E. Wagstaff, John Salman, Pamela Mardiak, Jozef Barrios, Carlos H. Zarba, Juan J. Gladkov, Oleg A. Lee, Eunsik Szczylik, Cezary McCann, Lauren Rubin, Stephen D. Chen, Mei Davis, Ian D.